Standout Papers

The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-a... 2019 2026 2021 2023 1.4k
  1. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis (2019)
    Zobair M. Younossi, Pegah Golabi et al. Journal of Hepatology
  2. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review (2023)
    Zobair M. Younossi, Pegah Golabi et al. Hepatology
  3. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD (2020)
    James M. Paik, Pegah Golabi et al. Hepatology
  4. Epidemiology of chronic liver diseases in the USA in the past three decades (2019)
    Zobair M. Younossi, Maria Stepanova et al. Gut
  5. Disease Burden of Hepatocellular Carcinoma: A Global Perspective (2019)
    Mehmet Sayıner, Pegah Golabi et al. Digestive Diseases and Sciences
  6. Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019 (2021)
    Pegah Golabi, James M. Paik et al. Journal of Hepatology
  7. Are there outcome differences between NAFLD and metabolic‐associated fatty liver disease? (2022)
    Zobair M. Younossi, James M. Paik et al. Hepatology
  8. The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes (2024)
    Zobair M. Younossi, Pegah Golabi et al. Clinical Gastroenterology and Hepatology

Immediate Impact

1 from Science/Nature 189 standout
Sub-graph 1 of 12

Citing Papers

Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
2025 Standout
Comparison of pharmacological therapies in metabolic dysfunction–associated steatohepatitis for fibrosis regression and MASH resolution: Systematic review and network meta-analysis
2025 Standout
123 intermediate papers

Works of Pegah Golabi being referenced

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease
2021
and 46 more

Author Peers

Author Last Decade Papers Cites
Pegah Golabi 5720 2747 969 2405 104 6.9k
Per Stål 5847 3525 1022 2096 132 7.4k
James M. Paik 5049 2144 868 2278 82 5.8k
Yoshio Sumida 5599 2845 683 2229 175 7.1k
Laura Wilson 4696 1823 679 1954 99 6.2k
Yuichiro Eguchi 4621 2888 680 1593 172 6.4k
Hideyuki Hyogo 4283 2117 751 1897 126 6.0k
Kathleen E. Corey 4564 2374 656 1830 165 6.6k
Mattias Ekstedt 7577 3905 1398 3121 99 8.3k
Stuart McPherson 5074 3054 706 1844 126 6.0k
Paola Loria 4265 1815 687 1873 108 6.2k

All Works

Loading papers...

Rankless by CCL
2026